The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The endogenous cannabinoid system controls extinction of aversive memories
Abstract
Acquisition and storage of aversive memories is one of the basic principles of central nervous systems throughout the animal kingdom. In the absence of reinforcement, the resulting behavioural response will gradually diminish to be finally extinct. Despite the importance of extinction, its cellular mechanisms are largely unknown. The cannabinoid receptor 1 (CB1) and endocannabinoids are present in memory-related brain areas and modulate memory. Here we show that the endogenous cannabinoid system has a central function in extinction of aversive memories. CB1-deficient mice showed strongly impaired short-term and long-term extinction in auditory fear-conditioning tests, with unaffected memory acquisition and consolidation. Treatment of wild-type mice with the CB1 antagonist SR141716A mimicked the phenotype of CB1-deficient mice, revealing that CB1 is required at the moment of memory extinction. Consistently, tone presentation during extinction trials resulted in elevated levels of endocannabinoids in the basolateral amygdala complex, a region known to control extinction of aversive memories. In the basolateral amygdala, endocannabinoids and CB1 were crucially involved in long-term depression of GABA (gamma-aminobutyric acid)-mediated inhibitory currents. We propose that endocannabinoids facilitate extinction of aversive memories through their selective inhibitory effects on local inhibitory networks in the amygdala.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Following their binding to central nervous system receptors (e.g.CB1 receptors), endocannabinoids have been shown, e.g., to reduce anxiety (Marsicano et al., 2002;Lutz et al., 2015) and increase food intake (Di Marzo et al., 2001).”
From Sleep restriction alters plasma endocannabinoids concentrations before but not after exercise in humans (2016) · cites this paper as Marsicano et al., 2002
In the citing paper
“Moreover, there is an emerging body of evidence demonstrating an important role for CB1 receptor-mediated endocannabinoid signaling in the extinction of aversive memories8.”
From Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study (2013) · cites this paper as [8]
In the citing paper
“As part of this protective role under aversive conditions, elevated EC signaling during stress has been shown to dampen the development of anxiety [12] and to regulate the encoding [13], retrieval [14] and extinction [15] of traumatic memories.”
From Plasma concentrations of endocannabinoids and related primary fatty acid amides in patients with post-traumatic stress disorder (2013) · cites this paper as [15]
In the citing paper
“Additionally, inhibition of FAAH facilitates long-term fear extinction and rescues deficient fear extinction in rodent models by enhancing AEA–CB1 (cannabinoid type 1) receptor signaling and synaptic plasticity in the BLA.”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“Marsicano and colleagues reported elevated AEA and 2-AG BLA levels after extinction training in mice [86]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“One notable finding is that a CB1R-dependent form of synaptic plasticity in BLA [51,86], long-term depression of inhibitory GABAergic transmission (LTDi), is enhanced by FAAH KO [51] and by the FAAH inhibitor AM3506 at doses that promote extinction [50].”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“and produced impairments in extinction learning (but not fear conditioning) by CB1R KO or systemic antagonist (SR141716A) administration [28,86]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“This suggests a scheme in which AEA released during extinction relieves a tonic inhibitory brake on BLA output neurons [50,51,86] necessary for the encoding of extinction memories [102] (Figure 2).”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [86]
In the citing paper
“The cannabinoid system is part of the complex circuitry that regulates anxiety and stress and is a crucial mediator of emotional learning (Marsicano et al, 2002;Viveros et al, 2005;Patel et al, 2005Patel et al, , 2005a; Laviolette and Grace, 2006;Varvel et al, 2007;Ganon-Elazar and Akirav, 2009;Lutz, 2009;Hill et al, 2009;Abush and Akirav, 2010;Akirav, 2011).”
From Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (2012) · cites this paper as Marsicano et al, 2002
Citations
Cites
LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Genetic enhancement of learning and memory in mice
Tang, Y., Shimizu, E., Dubé, G., Rampon, C., Kerchner, G. A., Zhuo, M., Liu, G., & Tsien, J. Z. (1999) · Nature · doi:10.1038/43432 · Cited by 1,878
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
The role of ventromedial prefrontal cortex in the recovery of extinguished fear
Quirk, G. J., Russo, G. K., Barron, J. L., & Lebron, K. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06225.2000 · Cited by 957 · cited 1×
“; however, there is increasing evidence that some cellular pathways are specifically involved in extinction, but not in acquisition or consolidation of fear memorie”
BackgroundMarsicano, G., & Lutz, B. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00847.x · Cited by 937
Self-citationExtinction of emotional learning: contribution of medial prefrontal cortex
Morgan, M. A., Romanski, L. M., & LeDoux, J. E. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90241-c · Cited by 897 · cited 1×
“To confirm this assumption, we measured in C57BL/6J mice levels of the two major endocannabinoids, anandamide (AEA) and 2-arachidonoylglycerol (2-AG), in brain punches of the medial prefrontal cortex (mPFC) and the basolateral amygdala complex (BLAC), both of which are thought to have central roles in extinction of av…”
BackgroundOhno‐Shosaku, T., Maejima, T., & Kano, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00247-1 · Cited by 874
Cannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Flagged first, then by citations
Research works printed but not linked: 1
- Franklin, K. B. J. & Paxinos, G. The Mouse Brain (Academic, San Diego, 1997)
Cited by
Sorted by citations
Items 401–500 of 1,005
Hölter, S. M., Kallnik, M., Wurst, W., Marsicano, G., Lutz, B., & Wotjak, C. T. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.01.008 · Cited by 100
Self-citationAlvares, L. D. O., Genro, B. P., Diehl, F., & Quillfeldt, J. A. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.01.009 · Cited by 99
Giordano, C., Cristino, L., Luongo, L., Siniscalco, D., Petrosino, S., Piscitelli, F., Marabese, I., Gatta, L., Rossi, F., Imperatore, R., et al. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr328 · Cited by 100
Akirav, I. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00034 · Cited by 102
Bosch-Bouju, C., Larrieu, T., Linders, L., Manzoni, O. J., & Layé, S. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.082 · Cited by 100
Functional Relevance of Endocannabinoid-Dependent Synaptic Plasticity in the Central Nervous System
Augustin, S. M., & Lovinger, D. M. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00508 · Cited by 100
Viganò, D., Guidali, C., Petrosino, S., Realini, N., Rubino, T., Marzo, V. D., & Parolaro, D. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009371 · Cited by 99
The Clinical Implications of Mouse Models of Enhanced Anxiety
Sartori, S. B., Landgraf, R., & Singewald, N. (2011) · Future Neurology · doi:10.2217/fnl.11.34 · Cited by 103
Atsak, P., Roozendaal, B., & Campolongo, P. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.08.047 · Cited by 98
Ganon-Elazar, E., & Akirav, I. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.01.014 · Cited by 98
Emotional Modulation of Learning and Memory: Pharmacological Implications
LaLumiere, R. T., McGaugh, J. L., & McIntyre, C. K. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013474 · Cited by 103
Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD
Udi, S., Hinden, L., Earley, B. J., Drori, A., Reuveni, N., Hadar, R., Çınar, R., Nemirovski, A., & Tam, J. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016101085 · Cited by 102
Endocannabinoid-Dependent Neocortical Layer-5 LTD in the Absence of Postsynaptic Spiking
Sjöström, P. J., Turrigiano, G. G., & Nelson, S. B. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00376.2004 · Cited by 97
Pattij, T., Janssen, M. C. W., Schepers, I. M., González‐Cuevas, G., Vries, T. J. D., & Schoffelmeer, A. N. M. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0773-4 · Cited by 99
Clarke, J. R., Rossato, J. I., Monteiro, S., Bevilaqua, L. R. M., Izquierdo, I., & Cammarota, M. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.04.009 · Cited by 97
Rodgers, R. J., Evans, P., & Murphy, A. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00013 · Cited by 101
Bucherelli, C., Baldi, E., Mariottini, C., Passani, M. B., & Blandina, P. (2006) · Learning & Memory · doi:10.1101/lm.326906 · Cited by 105
Medial prefrontal cortex neuronal circuits in fear behavior
Courtin, J., Bienvenu, T., Einarsson, E. Ö., & Herry, C. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.001 · Cited by 108
Lorenzetti, V., Solowij, N., Fornito, A., Lubman, D. I., & Yücel, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990435 · Cited by 99
Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice
Mock, E. D., Mustafa, M. A., Gunduz‐Cinar, O., Çınar, R., Petrie, G. N., Kantae, V., Di, X., Ogasawara, D., Varga, Z. V., Pálóczi, J., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-0528-7 · Cited by 97
Histamine in the brain: Beyond sleep and memory
Passani, M. B., Giannoni, P., Bucherelli, C., Baldi, E., & Blandina, P. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.12.002 · Cited by 95
Alvares, L. D. O., Genro, B. P., Breda, R. V., Pedroso, M. F., da Costa, J. C., & Quillfeldt, J. A. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.101 · Cited by 95
Endocannabinoid System: Emerging Role from Neurodevelopment to Neurodegeneration
Basavarajappa, B. S., Nixon, R. A., & Arancio, O. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709787847921 · Cited by 98
de la Fuente, V., Freudenthal, R., & Romano, A. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6066-10.2011 · Cited by 94
Jacob, W., Yassouridis, A., Marsicano, G., Monory, K., Lutz, B., & Wotjak, C. T. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00512.x · Cited by 95
Self-citationMorena, M., Berardi, A., Colucci, P., Palmery, M., Trezza, V., Hill, M. N., & Campolongo, P. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.305 · Cited by 96
de Bitencourt, R. M., & Takahashi, R. N. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00502 · Cited by 108
Endocannabinoids via CB 1 receptors act as neurogenic niche cues during cortical development
Díaz-Alonso, J., Guzmán, M., & Galve‐Roperh, I. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0385 · Cited by 94
Marsicano, G., & Kuner, R. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_10 · Cited by 103
Self-citationThe role of CB1 in immune modulation by cannabinoids
Kaplan, B. L. F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.004 · Cited by 92
CB1 receptor signaling regulates social anxiety and memory
Litvin, Y., Phan, A., Hill, M. N., Pfaff, D. W., & McEwen, B. S. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12045 · Cited by 99
The role of CB1 receptors in psychostimulant addiction
Wiskerke, J., Pattij, T., Schoffelmeer, A. N. M., & Vries, T. J. D. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00109.x · Cited by 91
Schaefer, C., Enning, F., Mueller, J. K., Bumb, J. M., Rohleder, C., Odorfer, T. M., Klosterkötter, J., Hellmich, M., Koethe, D., Schmahl, C., et al. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0470-8 · Cited by 92
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
Sidhpura, N., & Parsons, L. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.034 · Cited by 92
Tan, H., Lauzon, N. M., Bishop, S. F., Chi, N., Bechard, M., & Laviolette, S. R. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4718-10.2011 · Cited by 92
Concerted Action of CB1 Cannabinoid Receptor and Deleted in Colorectal Cancer in Axon Guidance
Argaw, A., Duff, G., Zabouri, N., Cécyre, B., Chainé, N., Cherif, H., Tea, N., Lutz, B., Ptito, M., & Bouchard, J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4134-09.2011 · Cited by 102
Self-citationThe endocannabinoid system as a target for the treatment of cannabis dependence
Clapper, J. R., Mangieri, R. A., & Piomelli, D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.018 · Cited by 94
Olango, W., Roche, M., Ford, G., Harhen, B., & Finn, D. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01478.x · Cited by 93
Lisboa, S. F. D. S., dos Reis, D. G., da Silva, A. L., Corrêa, F. M. D. A., Guimarães, F. S., & Resstel, L. B. M. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000684 · Cited by 91
CB1 receptor antagonism: biological basis for metabolic effects
Marzo, V. D. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.09.001 · Cited by 90
Li, Y., & Kim, J. (2015) · Neural Plasticity · doi:10.1155/2016/9817089 · Cited by 90
Bailey, C. R., Cordell, E., Sobin, S. M., & Neumeister, A. (2013) · CNS Drugs · doi:10.1007/s40263-013-0051-4 · Cited by 89
de Novellis, V., Vita, D., Gatta, L., Luongo, L., Bellini, G., De Chiaro, M., Marabese, I., Siniscalco, D., Boccella, S., Piscitelli, F., et al. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-7 · Cited by 90
Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes
Bosier, B., Bellocchio, L., Metna‐Laurent, M., Gómez, E. S., Matias, I., Hébert-Chatelain, É., Cannich, A., Maître, M., Lesté-Lasserre, T., Cardinal, P., et al. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.08.001 · Cited by 95
Self-citationRossi, F., Perrotta, S., Bellini, G., Luongo, L., Tortora, C., Siniscalco, D., Francese, M., Torella, M., Nobili, B., Marzo, V. D., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.104463 · Cited by 88
Ren, S., Wang, Z., Zhang, Y., & Chen, N. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0385-7 · Cited by 88
Rodgers, R. J., Haller, J., Halász, J., & Mikics, É. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02548.x · Cited by 88
Zhao, Y., & Tzounopoulos, T. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5303-10.2011 · Cited by 96
Foeller, E., Celikel, T., & Feldman, D. E. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00553.2005 · Cited by 88
Segev, A., Rubin, A. S., Abush, H., Richter‐Levin, G., & Akirav, I. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.292 · Cited by 90
Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors
Monte, F. H. D., de Souza, R. R., de Bitencourt, R. M., Kroon, J. A. V., & Takahashi, R. N. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.04.045 · Cited by 94
The CB1 Receptor as the Cornerstone of Exostasis
Piazza, P. V., Cota, D., & Marsicano, G. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.002 · Cited by 100
Self-citationFinn, D. P. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.05.011 · Cited by 91
Lack of CB1 receptor activity impairs serotonergic negative feedback
Aso, E., Renoir, T., Mengod, G., Ledent, C. A., Hamon, M., Maldonado, R. J., Lanfumey, L., & Valverde, O. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06025.x · Cited by 90
Bisogno, T., Martire, A., Petrosino, S., Popoli, P., & Marzo, V. D. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.031 · Cited by 86
Self-citationCholecystokinin: A multi‐functional molecular switch of neuronal circuits
Lee, S. Y., & Soltész, I. (2010) · Developmental Neurobiology · doi:10.1002/dneu.20815 · Cited by 84
The Promise of Extinction Research for the Prevention and Treatment of Anxiety Disorders
Anderson, K. C., & Insel, T. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.022 · Cited by 89
Kamprath, K., Romo-Parra, H., Häring, M., Gaburro, S., Doengi, M., Lutz, B., & Pape, H.-C. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.196 · Cited by 86
Self-citationSink, K. S., Segovia, K. N., Sink, J. R., Randall, P. A., Collins, L. E., Correa, M., Markus, E. J., Vemuri, K. V., Makriyannis, A., & Salamone, J. D. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.11.002 · Cited by 89
Petrosino, S., Cordaro, M., Verde, R., Moriello, A. S., Marcolongo, G., Schievano, C., Siracusa, R., Piscitelli, F., Peritore, A. F., Crupi, R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00249 · Cited by 89
The endocannabinoid system and nondrug rewarding behaviours
Fattore, L., Melis, M., Fadda, P., Pistis, M., & Fratta, W. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.020 · Cited by 96
Valdeolivas, S., Pazos, M. R., Bisogno, T., Piscitelli, F., Iannotti, F. A., Allarà, M., Sagredo, O., Marzo, V. D., & Fernández‐Ruíz, J. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.387 · Cited by 86
Self-citationBrindisi, M., Maramai, S., Gemma, S., Brogi, S., Grillo, A., Di Cesare Mannelli, L., Gabellieri, E., Lamponi, S., Saponara, S., Gorelli, B., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01812 · Cited by 86
Atsak, P., Hauer, D., Campolongo, P., Schelling, G., Fornari, R. V., & Roozendaal, B. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.334 · Cited by 85
Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review
Stockhorst, U., & Antov, M. I. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00359 · Cited by 96
Llorente, R., Llorente‐Berzal, A., Petrosino, S., Marco, E. M., Guaza, C., Prada, C., López‐Gallardo, M., Marzo, V. D., & Viveros, M. (2008) · Developmental Neurobiology · doi:10.1002/dneu.20666 · Cited by 85
de Lago, E., Petrosino, S., Valenti, M., Morera, E., Ortega‐Gutiérrez, S., Fernández‐Ruíz, J., & Marzo, V. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.05.011 · Cited by 86
Annuzzi, G., Piscitelli, F., Marino, L. D., Patti, L., Giacco, R., Costabile, G., Bozzetto, L., Riccardi, G., Verde, R., Petrosino, S., et al. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-43 · Cited by 85
Fatty Acid Amide Hydrolase: From Characterization to Therapeutics
Labar, G., & Michaux, C. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790157 · Cited by 86
Lovinger, D. M., Partridge, J. G., & Tang, K. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.014 · Cited by 86
Presynaptic plasticity: targeted control of inhibitory networks
McBain, C. J., & Kauer, J. A. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.05.008 · Cited by 79
Chapter 5 The Endocannabinoid System as A Target for Novel Anxiolytic and Antidepressant Drugs
Gaetani, S., Dipasquale, P., Romano, A., Righetti, L., Cassano, T., Piomelli, D., & Cuomo, V. (2009) · International Review of Neurobiology · doi:10.1016/s0074-7742(09)85005-8 · Cited by 83
Roche, M., O'Connor, E., Diskin, C., & Finn, D. P. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05861.x · Cited by 83
Trezza, V., & Campolongo, P. (2013) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2013.00100 · Cited by 87
Roberto, M., Cruz, M. T., Bajo, M., Siggins, G. R., Parsons, L. H., & Schweitzer, P. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.70 · Cited by 85
Role of Endocannabinoid Signaling in Anxiety and Depression
Patel, S., & Hillard, C. J. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_14 · Cited by 91
Maroun, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05169.x · Cited by 82
Impellizzeri, D., Siracusa, R., Cordaro, M., Crupi, R., Peritore, A. F., Gugliandolo, E., D’Amico, R., Petrosino, S., Evangelista, M., Paola, R. D., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.01.007 · Cited by 83
Qin, M., Xia, Z., Huang, T., & Smith, C. B. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.047 · Cited by 87
Arpana Agrawal, A., Nelson, E. C., Littlefield, A. K., Bucholz, K. K., Degenhardt, L. J., Henders, A. K., Madden, P. A. F., Martin, N. G., Montgomery, G. W., Pergadia, M. L., et al. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2273 · Cited by 88
Cannabinoids and emotionality: a neuroanatomical perspective
McLaughlin, R. J., & Gobbi, G. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.052 · Cited by 84
Addiction: A Disease of Volition Caused by a Cognitive Impairment
Campbell, W. G. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304801005 · Cited by 82
Non-pharmacological factors that determine drug use and addiction
Ahmed, S. H., Badiani, A., Miczek, K. A., & Müller, C. P. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.08.015 · Cited by 85
Tan, H., Lauzon, N. M., Bishop, S. F., Bechard, M. A., & Laviolette, S. R. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhp210 · Cited by 81
Fear relief—toward a new conceptual frame work and what endocannabinoids gotta do with it
Riebe, C. J. N., Pamplona, F. A., Kamprath, K., & Wotjak, C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.057 · Cited by 84
Self-citationMassi, L., Elezgarai, I., Puente, N., Reguero, L., Grandes, P., Manzoni, O. J., & Georges, F. E. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2291-08.2008 · Cited by 82
The role of endocannabinoid transmission in cocaine addiction
Arnold, J. C. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.02.015 · Cited by 81
Fride, E., Suris, R., Weidenfeld, J., & Mechoulam, R. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00016 · Cited by 83
Tsetsenis, T., Younts, T. J., Chiu, C. Q., Kaeser, P. S., Castillo, P. E., & Südhof, T. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112237108 · Cited by 81
The Peptide Hemopressin Acts through CB1Cannabinoid Receptors to Reduce Food Intake in Rats and Mice
Dodd, G. T., Mancini, G., Lutz, B., & Luckman, S. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5455-09.2010 · Cited by 81
Self-citationEndocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition
Cippitelli, A., Astarita, G., Duranti, A., Caprioli, G., Ubaldi, M., Stopponi, S., Kallupi, M., Sagratini, G., de Fonseca, F. R., Piomelli, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028142 · Cited by 81
Njoo, C., Agarwal, N. K., Lutz, B., & Kuner, R. (2015) · PLoS Biology · doi:10.1371/journal.pbio.1002286 · Cited by 79
Self-citationde Bitencourt, R. M., Pamplona, F. A., & Takahashi, R. N. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.039 · Cited by 80
Storozhuk, M., & Zholos, A. V. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170424120802 · Cited by 79
Lisboa, S. F. D. S., Niraula, A., Resstel, L. B. M., Guimarães, F. S., Godbout, J. P., & Sheridan, J. F. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0064-2 · Cited by 81
Rossi, S., Furlan, R., Chiara, V. D., Muzio, L., Musella, A., Motta, C., Studer, V., Cavasinni, F., Bernardi, G., Martino, G., et al. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.017 · Cited by 78
Self-citationChhatwal, J. P., Gutman, A. R., Maguschak, K. A., Bowser, M. E., Yang, Y., Davis, M., & Ressler, K. J. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.97 · Cited by 80
Fear extinction in rodents: basic insight to clinical promise
Barad, M. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.10.005 · Cited by 82
Anandamide and neutrophil function in patients with fibromyalgia
Kaufmann, I., Schelling, G., Eisner, C. B., Richter, H. P., Krauseneck, T., Vogeser, M., Hauer, D., Campolongo, P., Choukèr, A., Beyer, A., et al. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.02.009 · Cited by 80
The cannabinoid CB 1 receptor and the endocannabinoid anandamide: possible antidepressant targets
Bambico, F. R., & Gobbi, G. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.11.1347 · Cited by 80
Metadata
- Authors
- Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., Di Marzo, V., & Lutz, B.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- LMU Klinikum (DE)
- Istituto di Chimica Biomolecolare (IT)
- Helmholtz Munich (DE)
- Corresponding author
- Lutz, Beat
- Venue
- Nature
- Published
- 2002-08
- Volume
- 418
- Issue
- 6897
- Pages
- 530-534
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1982291289
- Cited by
- 1,728
- References
- 30
- Citations by year
- 2026: 22 · 2025: 39 · 2024: 41 · 2023: 48 · 2022: 60 · 2021: 61 · 2020: 60 · 2019: 70 · 2018: 64 · 2017: 77 · 2016: 75 · 2015: 87 · 2014: 90 · 2013: 87 · 2012: 85
- FWCI
- 42.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- endocannabinoid system, CB1 receptor, CB1 knockout mice, fear extinction, auditory fear conditioning, basolateral amygdala, long-term depression, GABAergic inhibition, SR141716A, memory consolidation, inhibitory neural networks
- MeSH terms
- Rimonabant, Acoustic Stimulation, Amygdala, Animals, Cannabinoids, Conditioning, Classical, Electrophysiology, Extinction, Psychological, Fear, gamma-Aminobutyric Acid, Male, Memory, Mice, Inbred C57BL, Neuronal Plasticity, Neurons, Piperidines, Pyrazoles, Receptors, Drug, Synapses, Gene Deletion, Mice, Knockout, Receptors, Cannabinoid, Mice, Cannabinoid Receptor Modulators, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
